Ubs Group Ag Roivant Sciences Ltd. Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 537,597 shares of ROIV stock, worth $5.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
537,597
Previous 233,889
129.85%
Holding current value
$5.91 Million
Previous $2.63 Million
115.77%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
267Shares Held
488MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$803 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$763 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$734 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$398 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$392 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.75B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...